India updates export regulations; AAIPharma continues exec suite turnover;

> India will announce new regulations for pharmaceutical exports to clearly identify product origin and manufacturer in an attempt to "tackle the campaigns on the quality of Indian generics and their wrongful identification with counterfeit drugs." Article

> AAIPharma Services, which last month announced the naming of Patrick Walsh as CEO, has appointed Tim Martin as executive VP for sales and marketing, and Rob Goshert as VP for corporate accounts.  AAIPharma Services release

> Takeda Pharma will build a pharma manufacturing plant in Hikari City, Japan, on the premises of its existing Hikari Plant located in Japan. Story

> Glenn Kazo has been named president at Prolong Pharmaceuticals in South Plainfield, NJ. Prolong release

> Protein production service supplier Laureate Pharma has appointed Steven Johnson to the post of VP for business development. Laureate release

Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.